Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Bridion®:MSD Merck Sharp & Dohme AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
V03AB35 - SugammadexATC-DDD Version 2016. Source: WHO
V - Various

This group comprises many different types of drugs, and assigning DDDs are difficult. Very few DDDs are assigned in this group.

V03 - All Other Therapeutic Products
V03A - All Other Therapeutic Products
V03AB - Antidotes

Sugammadex indicated for reversal of neuromuscular blockade induced by rocuronium or vecuronium is classified here.
Hydroxocobalamine is also classified in B03BA.
Medicinal charcoal is classified in A07BA.
Atropine is classified in A03BA.
Penicillamine, which is also used in copper poisoning, is classified in M01CC.
Silibinin, which is also used in amanita poisoning, is classified in A05BA at the same 5th level as silymarin.
Anticholinesterases, which are used as curare antidotes, are classified in N07AA.
Clonidine low strength tablets (e.g. 25 mcg) are classified in N02CX, even if the indication also may be "opioid withdrawal symptoms".
Both DL-methionine and L-methionine are included in the ATC 5th level V03AB26 - methionine.
Naltrexone is classified in N07BB - Drugs used in alcohol dependence.
Combinations of oxycodone and naloxone are classified in N02AA - Natural opium alkaloids.
Combinations of buprenorphine and naloxone are classified in N07BC - Drugs used in opioid dependence.

V03AB35 - Sugammadex
2021 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home